Published in Am J Respir Crit Care Med on December 01, 2001
Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis. Thorax (2004) 3.25
Infection control in cystic fibrosis. Clin Microbiol Rev (2004) 2.45
Clinical significance of microbial infection and adaptation in cystic fibrosis. Clin Microbiol Rev (2011) 2.23
Comparative assessment of genotyping methods for epidemiologic study of Burkholderia cepacia genomovar III. J Clin Microbiol (2002) 1.79
Bacterial activity in cystic fibrosis lung infections. Respir Res (2005) 1.74
The Burkholderia cepacia epidemic strain marker is part of a novel genomic island encoding both virulence and metabolism-associated genes in Burkholderia cenocepacia. Infect Immun (2004) 1.60
Sepsis, multiple organ failure, and death due to Pandoraea pnomenusa infection after lung transplantation. J Clin Microbiol (2003) 1.35
Comparison of matrix-assisted laser desorption ionization-time of flight (maldi-tof) mass spectrometry platforms for the identification of gram-negative rods from patients with cystic fibrosis. J Clin Microbiol (2013) 1.30
Novel pan-genomic analysis approach in target selection for multiplex PCR identification and detection of Burkholderia pseudomallei, Burkholderia thailandensis, and Burkholderia cepacia complex species: a proof-of-concept study. J Clin Microbiol (2010) 1.27
Laboratory aspects of management of chronic pulmonary infections in patients with cystic fibrosis. J Clin Microbiol (2003) 1.23
Predictors of non-referral of patients with cystic fibrosisfor lung transplant evaluation in the United States. J Cyst Fibros (2015) 1.11
Six-year molecular analysis of Burkholderia cepacia complex isolates among cystic fibrosis patients at a referral center for lung transplantation. J Clin Microbiol (2002) 1.06
Mortality associated with Acinetobacter baumannii infections experienced by lung transplant recipients. Lung (2010) 1.01
Fatal outcome of lung transplantation in cystic fibrosis patients due to small-colony variants of the Burkholderia cepacia complex. Eur J Clin Microbiol Infect Dis (2003) 1.01
Exacerbations in cystic fibrosis: 2 . prevention. Thorax (2007) 0.96
Burkholderia cepacia is associated with pulmonary hypertension and increased mortality among cystic fibrosis patients. J Clin Microbiol (2004) 0.95
Prevalence and clonality of Burkholderia cepacia complex genomovars in UK patients with cystic fibrosis referred for lung transplantation. Thorax (2004) 0.90
Disruption of tight junctions during traversal of the respiratory epithelium by Burkholderia cenocepacia. Infect Immun (2005) 0.88
Pediatric lung transplantation: indications and outcomes. J Thorac Dis (2014) 0.83
Bloodstream infections after solid-organ transplantation. Virulence (2016) 0.79
Effects of lung transplantation on inpatient end of life care in cystic fibrosis. J Cyst Fibros (2007) 0.79
The lung microbiome after lung transplantation. Expert Rev Respir Med (2014) 0.77
Lung transplantation for cystic fibrosis: results, indications, complications, and controversies. Semin Respir Crit Care Med (2015) 0.76
Clinafloxacin for Treatment of Burkholderia cenocepacia Infection in a Cystic Fibrosis Patient. Antimicrob Agents Chemother (2015) 0.75
Burkholderia cepacia complex in cystic fibrosis in a Brazilian reference center. Med Microbiol Immunol (2017) 0.75
A broad-spectrum probe for molecular epidemiology of bacteria: ribosomal RNA. J Infect Dis (1988) 10.73
Emergence of vancomycin resistance in coagulase-negative staphylococci. N Engl J Med (1987) 7.82
Recovery of resistant enterococci during vancomycin prophylaxis. J Clin Microbiol (1988) 5.71
Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr (1985) 4.26
Taxonomy and identification of the Burkholderia cepacia complex. J Clin Microbiol (2001) 4.02
Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium. J Clin Microbiol (1997) 3.33
Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis. J Clin Microbiol (1996) 3.20
Molecular epidemiology of Pseudomonas cepacia determined by polymerase chain reaction ribotyping. J Clin Microbiol (1992) 3.13
Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol (1985) 3.09
Evaluation of the United States pediatric urology workforce and fellowships: a series of surveys performed in 2006-2010. J Pediatr Urol (2011) 2.70
Selective and differential medium for recovery of Pseudomonas cepacia from the respiratory tracts of patients with cystic fibrosis. J Clin Microbiol (1987) 2.59
Misidentification of Burkholderia cepacia in US cystic fibrosis treatment centers: an analysis of 1,051 recent sputum isolates. Chest (2000) 2.41
Endemicity and inter-city spread of Burkholderia cepacia genomovar III in cystic fibrosis. J Pediatr (2001) 2.31
Transmission of multidrug-resistant serotype 23F Streptococcus pneumoniae in group day care: evidence suggesting capsular transformation of the resistant strain in vivo. J Infect Dis (1995) 2.31
Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex including biocontrol and cystic fibrosis-related isolates. Int J Syst Evol Microbiol (2001) 2.27
Nontuberculous mycobacteria in adult patients with cystic fibrosis. Chest (1992) 2.25
Improved recovery of mycobacteria from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol (1993) 2.22
Identification of Pandoraea species by 16S ribosomal DNA-based PCR assays. J Clin Microbiol (2001) 2.09
Invasive group A streptococcal infections in North Carolina: epidemiology, clinical features, and genetic and serotype analysis of causative organisms. J Infect Dis (1997) 2.09
Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge. Infect Immun (1996) 2.09
Three-dimensional volume rendering of spiral CT data: theory and method. Radiographics (1999) 2.00
Identification and detection of Stenotrophomonas maltophilia by rRNA-directed PCR. J Clin Microbiol (2000) 1.90
Utility of commercial systems for identification of Burkholderia cepacia complex from cystic fibrosis sputum culture. J Clin Microbiol (2000) 1.82
Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis. J Clin Microbiol (1987) 1.80
Identification of Bordetella spp. in respiratory specimens from individuals with cystic fibrosis. Clin Microbiol Infect (2008) 1.79
Biotype of Haemophilus influenzae: correlation with virulence and ampicillin resistance. J Infect Dis (1983) 1.78
A universal approach to bacterial molecular epidemiology by polymerase chain reaction ribotyping. J Infect Dis (1995) 1.77
Importance of culture in laboratory diagnosis of Bordetella pertussis infections. J Clin Microbiol (1984) 1.70
Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestis. Clin Infect Dis (1995) 1.69
Species-specific PCR as a tool for the identification of Burkholderia gladioli. J Clin Microbiol (2000) 1.65
Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients. Int J Syst Evol Microbiol (2001) 1.61
Relative frequency of Clostridium difficile in patients with diarrheal disease. J Clin Microbiol (1981) 1.56
Selection for vancomycin resistance in clinical isolates of Staphylococcus haemolyticus. J Infect Dis (1990) 1.54
Survival of human immunodeficiency virus in blood culture systems. Arch Pathol Lab Med (1988) 1.51
Multicenter evaluation of four methods for Clostridium difficile detection: ImmunoCard C. difficile, cytotoxin assay, culture, and latex agglutination. J Clin Microbiol (1996) 1.49
Short- and long-term efficacy of single-dose subunit vaccines against Yersinia pestis in mice. Am J Trop Med Hyg (1998) 1.49
Automatic liver segmentation technique for three-dimensional visualization of CT data. Radiology (1996) 1.44
Nasopharyngeal carriage of antibiotic-resistant pneumococci by children in group day care. J Infect Dis (1988) 1.42
Inapparent transmission of Pseudomonas (Burkholderia) cepacia among patients with cystic fibrosis. Pediatr Infect Dis J (1994) 1.34
Skeletal 3-D CT: advantages of volume rendering over surface rendering. Skeletal Radiol (1996) 1.32
Degenerate oligonucleotide primers for enzymatic amplification of recA sequences from gram-positive bacteria and mycoplasmas. J Bacteriol (1992) 1.32
Recovery of Burkholderia cenocepacia strain PHDC from cystic fibrosis patients in Europe. Thorax (2004) 1.32
Evaluation of four commercially available enzyme immunoassays for laboratory diagnosis of Clostridium difficile-associated diseases. J Clin Microbiol (1993) 1.28
Cloning and expression of the gene for an immunoglobulin G Fc receptor protein from a group A streptococcus. Infect Immun (1987) 1.25
Clinical, laboratory, and environmental features of infant botulism in Southeastern Pennsylvania. Pediatrics (1985) 1.24
Architecture of the vir regulons of group A streptococci parallels opacity factor phenotype and M protein class. J Bacteriol (1992) 1.22
Evaluation of a new generation of culture bottle using an automated bacterial culture system for detecting nine common contaminating organisms found in platelet components. Transfusion (2002) 1.22
Identification of members of the Burkholderia cepacia complex by species-specific PCR. J Clin Microbiol (2000) 1.21
Comparative in vitro activity of LY146032 (daptomycin), a new lipopeptide antimicrobial. Eur J Clin Microbiol (1987) 1.21
Capnocytophaga ochracea septicemia. J Clin Microbiol (1981) 1.18
Nutritional requirements for synthesis of heat-labile enterotoxin by enterotoxigenic strains of Escherichia coli. Infect Immun (1979) 1.18
Recovery of Pseudomonas cepacia and other Pseudomonas species from the environment. Infect Control Hosp Epidemiol (1995) 1.16
Sneakers as a source of Pseudomonas aeruginosa in children with osteomyelitis following puncture wounds. J Pediatr (1985) 1.16
Comparison of antimicrobial susceptibility methods for detection of penicillin-resistant Streptococcus pneumoniae. J Clin Microbiol (1995) 1.14
Utility of obtaining blood cultures in febrile neutropenic patients undergoing bone marrow transplantation. Bone Marrow Transplant (2000) 1.12
Evaluation of the campyslide agglutination test for confirmatory identification of selected Campylobacter species. J Clin Microbiol (1988) 1.09
Absorption of oral vancomycin - possible associated toxicity. Int J Pediatr Nephrol (1983) 1.08
Immune response to Yersinia outer proteins and other Yersinia pestis antigens after experimental plague infection in mice. Infect Immun (1999) 1.08
Dual-phase spiral CT angiography with volumetric 3D rendering for preoperative liver transplant evaluation: preliminary observations. J Comput Assist Tomogr (1998) 1.07
Characterization of PCR-ribotyping for Burkholderia (Pseudomonas) cepacia. J Clin Microbiol (1994) 1.07
Survival of Burkholderia cepacia on environmental surfaces. J Hosp Infect (1996) 1.06
The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome. Am J Respir Crit Care Med (1997) 1.04
Clostridium difficile in patients with cystic fibrosis. Am J Dis Child (1985) 1.03
Identification of two type IIa IgG-binding proteins expressed by a single group A streptococcus. J Immunol (1992) 1.02
A novel approach to insertional mutagenesis of Haemophilus influenzae. J Bacteriol (1991) 1.01
Clostridium difficile peritonitis in a neonate. A case report. Arch Pathol Lab Med (1984) 1.01
CT angiography with volume rendering: advantages and applications in splanchnic vascular imaging. Radiology (1996) 1.00
Pertussis is rare in human immunodeficiency virus disease. Am Rev Respir Dis (1993) 1.00
Source of Pseudomonas cepacia: ribotyping of isolates from patients and from the environment. J Pediatr (1993) 0.97
Evaluation of new monoclonal antibody-based latex agglutination test for detection of cryptococcal polysaccharide antigen in serum and cerebrospinal fluid. J Clin Microbiol (1994) 0.97
In vivo selection for transmissible drug resistance in Salmonella typhi during antimicrobial therapy. Antimicrob Agents Chemother (1990) 0.95
CT angiography with volume rendering: imaging findings. AJR Am J Roentgenol (1995) 0.94
Induction of immune response to the 17 kDa OMPA Burkholderia cenocepacia polypeptide and protection against pulmonary infection in mice after nasal vaccination with an OMP nanoemulsion-based vaccine. Med Microbiol Immunol (2009) 0.94
Clostridium difficile cytotoxin in a pediatric population. Am J Dis Child (1983) 0.93
CT angiography with volume rendering for quantifying vascular stenoses: in vitro validation of accuracy. AJR Am J Roentgenol (1999) 0.93
Evaluation of the contralateral inguinal ring in clinically unilateral inguinal hernia: a systematic review and meta-analysis. Hernia (2013) 0.92
Interactive three-dimensional volume rendering of spiral CT data: current applications in the thorax. Radiographics (1998) 0.92
Commercial use of Burkholderia cepacia. Emerg Infect Dis (1999) 0.91
Quality assurance study of bacterial antigen testing of cerebrospinal fluid. J Clin Microbiol (1995) 0.90
Burkholderia cepacia in cystic fibrosis. N Engl J Med (1995) 0.90
Reactivity of Haemophilus influenzae type b anti-pili antibodies. Microb Pathog (1989) 0.90
Immunological relationships between cholera toxin and Escherichia coli heat-labile enterotoxin. Infect Immun (1983) 0.90
Lung infection with Burkholderia gladioli in a child with cystic fibrosis: acute clinical and spirometric deterioration. Pediatr Pulmonol (1997) 0.89
Evaluation of the latex agglutination test for detection of Clostridium difficile. Arch Pathol Lab Med (1992) 0.89
An episodic outbreak of genetically related Burkholderia cepacia among non-cystic fibrosis patients at a university hospital. Infect Control Hosp Epidemiol (2001) 0.88
Abdominal image segmentation using three-dimensional deformable models. Invest Radiol (1998) 0.88
Epidemiology and natural history of urinary tract infections in children. Med Clin North Am (1991) 0.87
Construction of recombination-deficient strains of Streptococcus gordonii by disruption of the recA gene. J Bacteriol (1993) 0.87
Increased adherence of Staphylococcus aureus from cystic fibrosis lungs to airway epithelial cells. Am Rev Respir Dis (1993) 0.86
Cloning of the haemocin locus of Haemophilus influenzae type b and assessment of the role of haemocin in virulence. Microbiology (1998) 0.85
Renal artery stenosis: CT angiography--comparison of real-time volume-rendering and maximum intensity projection algorithms. Radiology (1999) 0.85
Role of capsule in adherence of Haemophilus influenzae type b to human buccal epithelial cells. Infect Immun (1987) 0.85
CT angiography: thoracic vascular imaging with interactive volume rendering technique. J Comput Assist Tomogr (1997) 0.82
Antigenuria after Haemophilus influenzae type b polysaccharide immunization: a prospective study. J Pediatr (1986) 0.81
Antigenuria after Haemophilus influenzae type b polysaccharide vaccination. J Pediatr (1986) 0.81
Virtual angioscopy using spiral CT and real-time interactive volume-rendering techniques. J Comput Assist Tomogr (1998) 0.81
Serological markers for hepatitis types A and B among United States Army blood donors. Mil Med (1981) 0.81
Rhizobium radiobacter bacteremia in a neonate. Infection (2011) 0.80
Pelvic muscle abscess. An unusual cause of gait disturbance in young children. Clin Pediatr (Phila) (1993) 0.80